Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation

  • Authors:
    • Li Feng
    • Jianguo Li
    • Ling Qin
    • Dan Guo
    • Hongyu Ding
    • Daping Deng
  • View Affiliations

    Affiliations: Ultrasound Department, Qianfoshan Hospital of Shandong Province, Jinan, Shandong 250014, P.R. China, Department of Human Anatomy, The School of Medicine of Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia 028041, P.R. China, Clinical Medicine Department, Taishan Medical University, Taian, Shandong 271016, P.R. China, Laboratory of Radiation Biology, The Radiation Medical Institute, Shandong Academy of Medical Sciences, Jinan, Shandong 250062, P.R. China
  • Published online on: August 3, 2018     https://doi.org/10.3892/etm.2018.6570
  • Pages: 3143-3148
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The radioprotective effect of lactoferrin (LF) was studied in mice subjected to sublethal X‑ray irradiation. The mice were randomly divided into the Control (non‑irradiated mice fed a standard diet without LF), IR (irradiated mice fed a standard diet) and IR+LF (irradiated mice fed LF) groups. The mice were fed daily for 7 days prior to irradiation and for 30 continuous days following irradiation. The survival ratio of the mice in the IR+LF group was significantly increased compared with the IR group between days 15 and 30 after irradiation. The body weight of the mice in the IR+LF group was increased compared with the IR group, and the difference was statistically significant. Blood was collected from the mice via the tail vein on days 2, 7, 14, 21 and 30 following irradiation. The laboratory indicators, including leukocyte, erythrocyte and platelet counts recovered more rapidly following irradiation in the IR+LF group compared with the IR group. Treatment of the irradiated mice with LF significantly reduced the DNA damage. In the hepatic tissue the level of superoxide dismutase in the IR+LF group was significantly increased, while malondialdehyde was significantly decreased compared with the IR group. These findings indicate that LF may prevent radiation damage and may have potential as a treatment for patients with cancer who receive radiotherapy.

Introduction

Radiotherapy is a common treatment method for a number of types of human cancer, with approximately half of all patients requiring radiotherapy for palliative or curative purposes (1). However, patients undergoing radiotherapy may develop adverse side-effects, including hematological toxicity, cytopenia, immune suppression and mucosal damage (2). Under ideal conditions, tumor tissue would receive a large dose of radiation, while normal healthy tissues would be protected from radiation injury. Therefore, the pathogenic processes induced by ionizing radiation and non-toxic radioprotective compounds that may protect normal tissues against radiation injury, are currently being extensively researched (3–5). Several compounds, including cysteine, aminothiol and cytokines, are known radioprotectors (6–8). Crescenti et al (9) reported that selenium, zinc and magnesium may also have radioprotective properties. Nishimura et al (10) reported that chitosan increased the hematocrit and survival rate in mice exposed to sublethal X-ray irradiation. Emami et al (11) reported that zinc exerted a protective effect against lethality in irradiated mice.

Lactoferrin (LF) is an 80 kDa iron-binding glycoprotein, which is a component of exocrine secretions, including milk and saliva and is also present in neutrophil granules (12). LF has been reported to serve a role in host defense and has various biological properties, including antimicrobial effects and modulation of cell growth (13,14). In addition to serving a key role in immune homeostasis, LF also reduces oxidative stress and may control excessive inflammatory responses (13,15,16). Recently, Sriramoju et al (17) reported that LF exerts various beneficial effects on humans and animals, including inhibition of carcinogenesis and prevention of drug-induced toxicity. Irradiated mice on an LF diet exhibited a significantly higher survival rate compared with mice fed a standard diet (18). The prevention of chemotherapy-induced ovarian disorders in mice receiving oral LF has also been reported (19). In addition, the use of a gel containing LF in patients with oral cancer who were treated with radiotherapy, increased salivary secretion, inhibited xerostomia and improved oral bacterial flora (20).

However, studies on the radioprotective effects of LF are limited. The aim of the present study was to investigate in vivo whether LF may enhance resistance to high doses of ionizing radiation in mice and to elucidate the possible mechanisms of action. To determine this, the survival ratio and hematopoietic system toxicity in mice receiving whole-body, high does (7.0 Gy) irradiation were assessed.

Materials and methods

Animals and irradiation

Male Balb/c mice (age, 6 weeks; weight, 20–23 g) were purchased from Unilever (Shanghai, China). All mice had free access to water and food; they were kept in a room maintained at 60±10% relative humidity and 20±2°C with a 12 h light/dark cycle. There were 5 mice per cage. A total of 60 mice were randomly assigned into 3 groups (n=20 per group) as follows: i) Control (non-irradiated mice fed a standard diet without LF); ii) IR (whole-body irradiated mice fed a standard diet without LF); and iii) IR+LF (whole-body irradiated mice fed a diet containing 0.1% bovine LF; Sigma-Aldrich, Merck KGaA, Darmstadt, Germany). The mice in the IR and IR+LF groups were exposed to a sublethal radiation dose (7.0 Gy). The control mice were sham irradiated. The mice were irradiated using a 6-MV linear accelerator at a dose rate of 0.865 Gy/min (PRIMUS High Energy; Siemens AG, Munich, Germany). The mice were fed for 7 days prior to irradiation and for 30 continuous days following irradiation. The study protocol was approved by the Ethics Committee of Qianfoshan Hospital of Shandong Province (Jinan, China).

Peripheral blood cell counts

Blood was collected from the mice via the tail vein in EDTA tubes (BD Biosciences, Franklin Lakes, NJ, USA) on days 0, 1, 2, 3, 9, 14, 19 and 29 following irradiation. The blood was centrifuged at 1,000 × g for 20 min at 20±2°C and evaluated using an automated hematology analyzer (pocH-100i; Sysmex Corporation, Kobe, Japan) to provide the complete blood cell counts. The measurements included leukocyte, erythrocyte and platelet (PLT) counts, as well the hemoglobin. The normal references value of hematological parameters were described previously (21).

Lymphocyte isolation and comet assay

A volume of 0.15 ml whole blood was layered onto the lymphocyte separation medium (cat. no. MRGMA0; R&D Systems, Inc., Minneapolis, MN, USA) and centrifuged for 2 min at 3,500 × g at 20±2°C. The lymphocytes were subsequently transferred to a 1.5 ml tube containing 1.2 ml 0.1 M PBS and centrifuged for 5 min at 2,000 × g at 20±2°C. The lymphocytes were washed twice with PBS. The cells were then suspended in PBS and the density was adjusted to 5–6×104/ml. A comet assay was performed under neutral conditions as described by Banath et al (22), with a slight modification. Specifically, special comet slides were used as opposed to conventional slides. All comet images were analyzed using CASP Lab software (version 1.2.3b2; CASPLab, Wroclaw, Poland) (23) and the percentage of DNA in the Olive Tail Moment (OTM) was recorded to characterize the lymphocytic DNA damage.

Biochemical analysis

The livers were removed, fixed in 4% paraformaldehyde solution at room temperature for 20 min and ground 30 days after radiation (5 mice per group). The obtained cells were washed with PBS and suspended in EDTA. Superoxide dismutase (SOD) and malondialdehyde (MDA) activities in the liver were analyzed using SOD and MDA assay kits (Beyotime Institute of Biotechnology, Haimen, China) according to the manufacturer's protocol.

Statistical analysis

Data are presented as the mean ± standard deviation (≥5 mice per group at each time point). Statistical analysis was performed using one-way analysis of variance with a post hoc Tukey's test (multiple comparison test) to determine the significance of differences among multiple groups. P<0.05 was considered to indicate a statistically significant difference. SPSS version 13.0 software (SPSS, Inc., Chicago, IL, USA) was used for the analyses.

Results

LF increases the survival rate of mice exposed to irradiation

In the present study, mice in the IR and IR+LF groups were exposed to 7 Gy radiation. The survival rate was monitored on days 1–30 following irradiation (Fig. 1). Kaplan-Meier analysis indicated that survival rates were significantly higher in the IR+LF group compared with the IR group between day 12 and 30 (P<0.05). On day 30 the survival rate of the IR+LF group was 50% and the survival rate of the IR group was 33%. The survival rate in the IR+LF group was significantly higher compared with that of the IR group (P<0.05). The differences between the IR+LF group and the control were also statistically significant (P<0.05). These results suggest that LF increased the survival rate of mice following exposure to radiation.

Figure 1.

Survival rates of irradiated mice. Each vertical bar indicates the standard deviation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

LF reduces the radiation-induced decrease in body weight

The body weights of the mice were measured at various time points following irradiation and the mean weight ± standard deviation was calculated among surviving mice (Fig. 2). The results revealed that the body weights significantly increased in the control group, remained mostly constant in the IR+LF group and decreased slightly in the IR group between day 8 and 10 after irradiation. Statistical analysis indicated that body weight was significantly higher in the IR+LF group compared with the IR group between days 20 and 30 (P<0.05). Furthermore, the body weights of the mice in the control group were significantly greater compared with the IR+LF group on days 20 and 25 (P<0.05). Furthermore, on day 30, no significant differences in body weight were identified between the control group and the IR+LF group.

Figure 2.

Body weights of irradiated mice. Each vertical bar indicates the standard deviation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

LF enhances hematological repopulation following whole-body irradiation

Hematological parameters were recorded following irradiation, including changes in the leukocyte count (Fig. 3). The leukocyte count in the IR+LF group exhibited a progressive decline to 1.9×109/l on day 3. In addition, the leukocyte count appears to stay steady between days 9 and 14 in the IR+LF group at ~2.6×103/µl. On day 29 the leukocyte count of the IR+LF mice had stabilized to within the normal range (7.6×109−10.9×109/l) (21). The significant difference was identified between the control group and the IR+LF group except on day 29 (P<0.05). However, the leukocyte count of the IR mice remained low (0.35×109/l) until day 14. Between day 9 and 29, the leukocyte counts in the IR group were significantly lower compared with the IR+LF group (P<0.05).

Figure 3.

Leukocyte counts of mice following irradiation. Each vertical bar indicates the standard deviation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

In the IR+LF group the erythrocyte count decreased to 4.6×1012/l on day 9 and gradually recovered to a value of 6.47×1012/l on day 14 (Fig. 4). No significant difference was identified between the control group and the IR+LF group on day 29. In the IR group the erythrocyte count decreased to 2.17×1012/l on day 9. From day 9, the erythrocyte count in the IR+LF group was significantly greater compared with the IR group (P<0.05). The control group was significantly greater compared with the IR group between day 3 and 29 (P<0.05). These results indicate that LF improved erythrocyte repopulation in the mice.

Figure 4.

Erythrocite counts of mice following irradiation. Each vertical bar indicates the standard deviation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

Following a decrease post irradiation, the PLT count in the IR+LF group was restored to within a normal range on day 19 (Fig. 5) (21). However, in the IR group, the PLT count decreased to a minimum value at day 9 and slowly increased to a normal level (21) by day 29. The IR+LF group was significantly greater compared with the IR group between day 1 aand 9, and 19 and 29 (P<0.05). The control group was significantly greater compared with the IR and IR+LF group (P<0.05). No significant difference was identified between the control group and the IR+LF group on day 29. These results indicate that LF improved PLT repopulation in the mice.

Figure 5.

Platelet counts of mice following irradiation. Each vertical bar indicates the standard deviation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

The results also demonstrated that IR induced a significant decrease in the level of hemoglobin between days 7 and 21 following irradiation. Post irradiation, the hemoglobin levels in the IR+LF and IR groups were significantly lower compared with the control group (P<0.05; Fig. 6). The hemoglobin level recovered faster and was consistently increased in the IR+LF group compared with the IR group. The hemoglobin levels in the IR+LF group were significantly higher compared with the IR group (P<0.05). These results indicate that LF significantly enhanced the recovery of hemoglobin during the experimental period compared with the IR group.

Figure 6.

Hemoglobin levels of mice following irradiation. Each vertical bar indicates the standard deviation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

LF increases antioxidant capacity

The MDA level is associated with lipid peroxidation in the liver (24). The MDA level in hepatic tissue was significantly lower in the IR+LF group compared with the IR group, which suggests that the LF diet prevented hepatic lipid peroxidation (Table I). SOD activity indicates the generation of oxidative stress (25). The protective response to oxidative damage in the liver of IR mice decreased significantly following irradiation compared with the control group. However, the LF diet significantly prevented the change in SOD activity compared with the IR group.

Table I.

MDA level and SOD activity in hepatic tissue.

Table I.

MDA level and SOD activity in hepatic tissue.

GroupSOD (U/ml)MDA (pmol/l)
Control41.25±0.414.31±0.02
IR 21.52±0.24a 7.31±0.12a
IR+LF 42.56±0.71b 4.98±0.42b

a P<0.05 vs. the Control.

b P<0.05 vs. the IR group. Data are presented as the mean ± standard deviation. n=5 per group. IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin; SOD, superoxide dismutase.

LF decreases the OTM of lymphocytes following irradiation

Irradiation led to the breakage of DNA chains. The OTM percentage 24, 48 and 72 h post irradiation in the IR+LF group was significantly greater and lesser compared with the control and IR groups, respectively (P<0.05; Fig. 7). Following unwinding, DNA was affected by the electric field in the electrophoresis liquid, forming the distinctive comet tail formation (Fig. 8).

Figure 7.

Olive Tail Moment of lymphocytes following irradiation. Data are presented as the mean ± standard deviation (5 mice/group/time point). IR, irradiated mice fed a standard diet; IR+LF, irradiated mice fed lactoferrin. *P<0.05 vs. the control group; #P<0.05 vs. the IR group.

Figure 8.

Comet images of lymphocytes following irradiation. Comet images were analyzed by CASPLab software.

Discussion

A number of substances with radioprotective properties have been previously reported (26). Intraperitoneal injection of purified ginseng extract following 6.5 Gy X-ray irradiation significantly increased the 30 day survival rate in mice (27). In addition, Shigoka extract prepared from Acathopanax senticosus was also reported to increase the post-irradiation survival rate in mice (28). The aim of the present study was to demonstrate the protective effects exerted by LF against radiation-induced injury in mice. The results demonstrated that at day 30 following irradiation the survival rate of the mice was 17% higher in IR+LF group compared with the mice in the IR group, demonstrating that an LF diet significantly improves survival rates.

It has been previously established that the survival rate of mice following exposure to a sublethal dose of radiation depends, on the recovery of the hematopoietic system (29,30). To determine whether LF protects mice from IR-induced hematopoietic system injury, the mice were exposed to X-ray irradiation at a dose of 7.0 Gy.

It is known that the number of leukocytes is correlated with the radiation dose (31). The IR+LF group exhibited a rapid increase in the leukocyte count from day 14 onwards and on day 29 the count was restored to normal levels. However, in the IR group, the leukocyte count began to increase at day 14 in the IR group, but the count remained at a lower level. These results indicate that LF stimulated the recovery of leukocytes and exerted a radioprotective effect.

In the IR group the PLT count exhibited an initial decline following X-ray irradiation and on day 9 the count was at its lowest level, however it returned to normal by day 29. The IR+LF group exhibited a faster increase in PLTs compared with the IR group and they recovered to near normal levels at day 19. It has been previously reported that when infants were fed an LF-supplemented infant formula, their hemoglobin value was increased compared with the group fed a conventional infant formula (32); similar results were also observed in female marathon runners (33). In the present study, the red blood cell count and hemoglobin levels were increased in the IR+LF group compared with the IR group following irradiation, which indicates that LF exerted hematopoietic or radioprotective effects.

Radiation may increase the oxidative capacity and induce damage to cellular molecules; previous biochemical studies have been performed to define normal MDA and SOD levels in liver tissue (34–36). The results of the present study revealed that the MDA level in the hepatic tissue was significantly lower in the IR+LF group compared with the IR group, while SOD activity was significantly increased. These results reveal that LF exerted a protective effect on cellular molecules against radiation-induced oxidative damage.

The comet assay, which detects DNA damage, has been widely used in radiation biology (37–40). The comet assay is a rapid and sensitive microdosimetric technique, particularly useful in radiation accidents (41). In the IR+LF and IR groups, the comet assay was used to observe the degree of DNA damage by irradiation. The IR group exhibited a substantial increase in DNA damage, even at 30 days post irradiation, while the IR+LF mice exhibited significantly reduced DNA damage. The present study demonstrated that significant differences were identified between the IR group and IR+LF group following irradiation. Therefore, the comet assay demonstrated that LF effectively reduced radiation-induced DNA injury.

In conclusion, the results of the present study suggest that LF increases PLT and leukocyte counts and reduces DNA damage in mice following high-dose irradiation. In the future LF may have potential as a radioprotector to reduce the adverse effects of radiotherapy. However, the exact mechanism of action of LF has not yet been fully elucidated. Therefore, further studies are required to determine whether radioscavenging or trapping is involved in this effect and to clarify the value of LF within the field of radiation protection.

Acknowledgements

Not applicable.

Funding

The present study was supported by the Natural Science Foundation of Shandong (grant no. 2010GSF10251), the Natural Science Foundation of Shandong (grant no. ZR2014YL027), the Natural Science Foundation of Inner Mongolia Autonomous Region of China (grant no. 2016MS0814) and the National Natural Science Foundation of China (grant no. 81760567).

Availability of data and materials

All data generated or analyzed during the current study are included in this published article.

Authors' contributions

LF fed the animals, collected blood from the mice and was a major contributor in the writing of the manuscript. DG performed the irradiation. DPD performed the histological examination. HYD performed the superoxide dismutase and malondialdehyde ELISAs. LQ analyzed the peripheral blood cells. JGL performed the lymphocyte isolation and comet assays. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The present study was approved by the Ethics Committee of Qianfoshan Hospital Affiliated to Shandong University.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Jung J, Kim H, Yoon SM, Cho B, Kim YJ, Kwak J and Kim JH: Targeting accuracy of image-guided stereotactic body radiation therapy for hepatocellular carcinoma in real-life clinical practice: In vivo assessment using hepatic parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images. Int J Radiat Oncol Biol Phys. S0360-3016:30811–30813. 2018.

2 

Kavitha M, Mubeen K and Vijayalakshmi KR: A study on Evaluation of efficacy of bethanechol in the management of chemoradiation-induced xerostomia in oral cancer patients. J Oral Maxillofac Pathol. 21:459–460. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Szybalski W: Molecular events resulting in radiation injury, repair and sensitization of DNA, Radiation research. Supplement. 7:147–159. 1967.

4 

Yazdi Keramati F, Monfared Shabestani A, Tashakkorian H, Mahmoudzadeh A and Borzoueisileh S: Radioprotective effect of Zamzam (alkaline) water: A cytogenetic study. J Environ Radioact. 167:166–169. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Kirakosyan G, Torgomyan H, Malakyan M, Bajinyan S and Trchounian A: Protective effect of some amino acids synthesized derivatives and their chelates on Escherichia coli under X-ray irradiation. Indian J Biochem Biophys. 50:289–295. 2013.PubMed/NCBI

6 

Greenberger JS, Clump D, Kagan V, Bayir H, Lazo JS, Wipf P, Li S, Gao X and Epperly MW: Strategies for discovery of small molecule radiation protectors and radiation mitigators. Front Oncol. 1:592012. View Article : Google Scholar : PubMed/NCBI

7 

Kunwar A, Adhikary B, Jayakumar S, Barik A, Chattopadhyay S, Raghukumar S and Priyadarsini KI: Melanin, a promising radioprotector: Mechanisms of actions in a mice model. Toxicol Appl Pharmacol. 264:202–211. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Rostami A, Moosavi SA, Changizi V and Ardakani Abbasian A: Radioprotective effects of selenium and vitamin-E against 6MV X-rays in human blood lymphocytes by micronucleus assay. Med J Islam Repub Iran. 30:3672016.PubMed/NCBI

9 

Crescenti E, Croci M, Medina V, Sambuco L, Bergoc R and Rivera E: Radioprotective potential of a novel therapeutic formulation of oligoelements Se, Zn, Mn plus Lachesis muta venom. J Radiat Res. 50:537–544. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Nishimura Y, Kim HS, Ikota N, Arima H, Bom HS, Kim YH, Watanabe Y, Yukawa M and Ozawa T: Radioprotective effect of chitosan in sub-lethally X-ray irradiated mice. J Radiat Res. 44:53–58. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Emami S, Hosseinimehr SJ, Taghdisi SM and Akhlaghpoor S: Kojic acid and its manganese and zinc complexes as potential radioprotective agents. Bioorg Med Chem Lett. 17:45–48. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Bruni N, Capucchio MT, Biasibetti E, Pessione E, Cirrincione S, Giraudo L, Corona A and Dosio F: Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine. Molecules. 21:pii: E752. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Baveye S, Elass E, Mazurier J, Spik G and Legrand D: Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med. 37:281–286. 1999. View Article : Google Scholar : PubMed/NCBI

14 

Berlutti F, Pantanella F, Natalizi T, Frioni A, Paesano R, Polimeni A and Valenti P: Antiviral properties of lactoferrin-a natural immunity molecule. Molecules. 16:6992–7018. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Inamori M, Togawa J, Matsumoto S, Harad K, Matsuura M, Iida H, Akimoto K, Endo H, Nonaka T, Takahashi H, et al: Protective effect of lactoferrin on acute acid reflux-induced esophageal mucosal damage. Hepatogastroenterology. 61:1595–1600. 2014.PubMed/NCBI

16 

Kruzel ML and Zimecki M: Lactoferrin and immunologic dissonance: Clinical implications. Arch Immunol Ther Exp (Warsz). 50:399–410. 2002.PubMed/NCBI

17 

Sriramoju B, Kanwar RK and Kanwar JR: Lactoferrin induced neuronal differentiation: A boon for brain tumours. Int J Dev Neurosci. 41:28–36. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Sakai M, Matsushita T, Hoshino R, Ono H, Ikai K and Sakai T: Identification of the protective mechanisms of Lactoferrin in the irradiated salivary gland. Sci Rep. 7:97532017. View Article : Google Scholar : PubMed/NCBI

19 

Horiuchi Y, Higuchi T, Tatsumi K, Takakura K, Fujii S and Konishi I: Lactoferrin is associated with a decrease in oocyte depletion in mice receiving cyclophosphamide. Fertil Steril. 91 5 Suppl:S2069–S2078. 2009. View Article : Google Scholar

20 

Nagy K, Urban E, Fazekas O, Thurzo L and Nagy E: Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. J Craniofac Surg. 18:1157–1164. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Bella LM, Fieri I, Tessaro FHG, Nolasco EL, Nunes FPB, Ferreira SS, Azevedo CB and Martins JO: Vitamin D modulates hematological parameters and cell migration into peritoneal and pulmonary cavities in alloxan-diabetic mice. Biomed Res Int. 2017:76518152017. View Article : Google Scholar : PubMed/NCBI

22 

Banath JP, Fushiki M and Olive PL: Rejoining of DNA single- and double-strand breaks in human white blood cells exposed to ionizing radiation. Int J Radiat Biol. 73:649–660. 1998. View Article : Google Scholar : PubMed/NCBI

23 

Końca K, Lankoff A, Banasik A, Lisowska H, Kuszewski T, Góźdź S, Koza Z and Wojcik A: A cross-platform public domain PC image-analysis program for the comet assay. Mutat Res. 534:15–20. 2003. View Article : Google Scholar : PubMed/NCBI

24 

El-Mihi KA, Kenawy HI, El-Karef A, Elsherbiny NM and Eissa LA: Naringin attenuates thioacetamide-induced liver fibrosis in rats through modulation of the PI3K/Akt pathway. Life Sci. 187:50–57. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Jindal A, Mahesh R, Bhatt S and Pandey D: Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model. Neurochem Int. 111:3–11. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Smith TA, Kirkpatrick DR, Smith S, Smith TK, Pearson T, Kailasam A, Herrmann KZ, Schubert J and Agrawal DK: Radioprotective agents to prevent cellular damage due to ionizing radiation. J Transl Med. 15:2322017. View Article : Google Scholar : PubMed/NCBI

27 

Verma P, Jahan S, Kim TH and Goyal PK: Management of radiation injuries by panax ginseng extract. J Ginseng Res. 35:261–271. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Jagetia GC and Baliga MS: Polyherbal extract of septilin protects mice against whole body lethal dose of gamma radiation. Phytother Res. 18:619–623. 2004. View Article : Google Scholar : PubMed/NCBI

29 

Liu C, Liu J, Hao Y, Gu Y, Yang Z, Li H and Li R: 6,7,3′,4′-Tetrahydroxyisoflavone improves the survival of whole-body-irradiated mice via restoration of hematopoietic function. Int J Radiat Biol. 93:793–802. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Li ZT, Wang LM, Yi LR, Jia C, Bai F, Peng RJ, Yu ZY, Xiong GL, Xing S, Shan YJ, et al: Succinate ester derivative of δ-tocopherol enhances the protective effects against 60Co γ-ray-induced hematopoietic injury through granulocyte colony-stimulating factor induction in mice. Sci Rep. 7:403802017. View Article : Google Scholar : PubMed/NCBI

31 

Erexson GL, Kligerman AD, Bryant MF, Sontag MR and Halperin EC: Induction of micronuclei by X-radiation in human, mouse and rat peripheral blood lymphocytes. Mutat Res. 253:193–198. 1991. View Article : Google Scholar : PubMed/NCBI

32 

King JC Jr, Cummings GE, Guo N, Trivedi L, Readmond BX, Keane V, Feigelman S and de Waard R: A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J Pediatr Gastroenterol Nutr. 44:245–251. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Koikawa N, Nagaoka I, Yamaguchi M, Hamano H, Yamauchi K and Sawaki K: Preventive effect of lactoferrin intake on anemia in female long distance runners. Biosci Biotechnol Biochem. 72:931–935. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Yaribeygi H, Mohammadi MT and Sahebkar A: Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats. Biomed Pharmacother. 98:333–337. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Koc M, Taysi S, Buyukokuroglu Emin M and Bakan N: The effect of melatonin against oxidative damage during total-body irradiation in rats. Radiat Res. 160:251–255. 2003. View Article : Google Scholar : PubMed/NCBI

36 

Zhang B, Su Y, Ai G, Wang Y, Wang T and Wang F: Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J Radiat Res. 46:305–312. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Hoffmann H and Speit G: Assessment of DNA damage in peripheral blood of heavy smokers with the comet assay and the micronucleus test. Mutat Res. 581:105–114. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Li J, Wang Y, DU L, Xu C, Cao J, Wang Q, Liu Q and Fan F: Nested PCR for mtDNA-4977-bp deletion and comet assay for DNA damage-a combined method for radiosensitivity evaluation of tumor cells. Oncol Lett. 7:1083–1087. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Olive PL, Banáth JP and Durand RE: Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the ‘comet’ assay. 1990. Radiat Res. 178:AV35–AV42. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Seidel C, Lautenschlager C, Dunst J and Muller AC: Factors influencing heterogeneity of radiation-induced DNA-damage measured by the alkaline comet assay. Radiat Oncol. 7:612012. View Article : Google Scholar : PubMed/NCBI

41 

Sirota NP and Kuznetsova EA: The comet assay application in radiobiological investigations. Radiats Biol Radioecol. 50:329–339. 2010.(In Russian). PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Feng L, Li J, Qin L, Guo D, Ding H and Deng D: Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation . Exp Ther Med 16: 3143-3148, 2018.
APA
Feng, L., Li, J., Qin, L., Guo, D., Ding, H., & Deng, D. (2018). Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation . Experimental and Therapeutic Medicine, 16, 3143-3148. https://doi.org/10.3892/etm.2018.6570
MLA
Feng, L., Li, J., Qin, L., Guo, D., Ding, H., Deng, D."Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation ". Experimental and Therapeutic Medicine 16.4 (2018): 3143-3148.
Chicago
Feng, L., Li, J., Qin, L., Guo, D., Ding, H., Deng, D."Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation ". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3143-3148. https://doi.org/10.3892/etm.2018.6570
Copy and paste a formatted citation
x
Spandidos Publications style
Feng L, Li J, Qin L, Guo D, Ding H and Deng D: Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation . Exp Ther Med 16: 3143-3148, 2018.
APA
Feng, L., Li, J., Qin, L., Guo, D., Ding, H., & Deng, D. (2018). Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation . Experimental and Therapeutic Medicine, 16, 3143-3148. https://doi.org/10.3892/etm.2018.6570
MLA
Feng, L., Li, J., Qin, L., Guo, D., Ding, H., Deng, D."Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation ". Experimental and Therapeutic Medicine 16.4 (2018): 3143-3148.
Chicago
Feng, L., Li, J., Qin, L., Guo, D., Ding, H., Deng, D."Radioprotective effect of lactoferrin in mice exposed to sublethal X‑ray irradiation ". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3143-3148. https://doi.org/10.3892/etm.2018.6570
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team